Chinese cure for idiopathic thrombocytopenic purpura in clinical research.docVIP

 PAGE \* MERGEFORMAT 8 Chinese cure for idiopathic thrombocytopenic purpura in clinical research Idiopathic thrombocytopenic purpura (ITP) Is bleeding and peripheral thrombocytopenia, bone marrow megakaryocytes, accompanied by an increase in the number of normal or mature as the main obstacle to the common clinical manifestations of hemorrhagic disease. It is well established in patients with this disease is a body due to production of anti-platelet autoantibodies, and autoimmune related, resulting in reduced platelet life span, damaged too much, reduce the number of pathological features of autoimmune disease. In this paper, where I from October 1995 to October 2001 admitted to the clinical data integrity, use of steroids, immunosuppressive agents and hormonal withdrawal of efficacy was not obvious by sensitive patients, the use of pure Chinese medicine treatment of 100 cases. Has achieved satisfactory results, are summarized below. General Information 24 cases of male and female 76 cases of acute type, 12 cases of chronic 88 cases, onset age of 7-62 years the average age of 35 years. The shortest duration of 6 months, the longest 84 months, with an average duration of 15 months. Are applied in all cases hormones, immunosuppressive agents is not obvious and the effect of hormone withdrawal by sensitive or can not be applied because of contraindications patients. Among them 39 patients had used immunosuppressive therapy. All patients were first adopted in December 1986 the Chinese Society of Hematology National Conference on Thrombosis and hemostasis revised standards. A reduction in platelet count repeated laboratory tests; 2 spleen does not increase or slightly increased; three the number of bone marrow megakaryocytes increased or normal, there are mature obstacles; four platelet antibodies increased; 5 to exclude secondary thrombocytopenia. Treatment Syndrome differentiation based on the clinical manifestations were divided